237 related articles for article (PubMed ID: 26116277)
1. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
[TBL] [Abstract][Full Text] [Related]
3. Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba.
Zheng B; Yang S; Fan C; Bi Y; Du L; Zhao L; Lee RJ; Teng L; Teng L; Xie J
Drug Deliv; 2016 May; 23(4):1194-203. PubMed ID: 26635185
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract.
Jin Y; Wen J; Garg S; Liu D; Zhou Y; Teng L; Zhang W
Int J Nanomedicine; 2013; 8():421-30. PubMed ID: 23378764
[TBL] [Abstract][Full Text] [Related]
6. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
7. Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Iwamoto K; Kawamoto H; Takeshita F; Matsumura S; Ayaki I; Moriyama T; Zaima N
J Oleo Sci; 2019 Sep; 68(9):923-930. PubMed ID: 31413248
[TBL] [Abstract][Full Text] [Related]
8. A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine.
Bi Y; Lv B; Li L; Lee RJ; Xie J; Qiu Z; Teng L
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947655
[TBL] [Abstract][Full Text] [Related]
9. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.
Bobbala SK; Veerareddy PR
J Liposome Res; 2012 Dec; 22(4):285-94. PubMed ID: 22762199
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats.
Kubota Y; Kobayashi K; Tanaka N; Nakamura K; Kunitomo M; Umegaki K; Shinozuka K
J Pharm Pharmacol; 2004 Mar; 56(3):401-5. PubMed ID: 15025867
[TBL] [Abstract][Full Text] [Related]
11. An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice.
Kuribara H; Weintraub ST; Yoshihama T; Maruyama Y
J Nat Prod; 2003 Oct; 66(10):1333-7. PubMed ID: 14575433
[TBL] [Abstract][Full Text] [Related]
12. Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.
Kressmann S; Biber A; Wonnemann M; Schug B; Blume HH; Müller WE
J Pharm Pharmacol; 2002 Nov; 54(11):1507-14. PubMed ID: 12495553
[TBL] [Abstract][Full Text] [Related]
13. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
[TBL] [Abstract][Full Text] [Related]
14. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.
Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC
J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
[TBL] [Abstract][Full Text] [Related]
16. Self-emulsifying drug delivery systems for improving oral absorption of ginkgo biloba extracts.
Tang J; Sun J; Cui F; Zhang T; Liu X; He Z
Drug Deliv; 2008 Nov; 15(8):477-84. PubMed ID: 18720135
[TBL] [Abstract][Full Text] [Related]
17. Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine.
Kennedy DO; Haskell CF; Mauri PL; Scholey AB
Hum Psychopharmacol; 2007 Jun; 22(4):199-210. PubMed ID: 17457961
[TBL] [Abstract][Full Text] [Related]
18. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
[TBL] [Abstract][Full Text] [Related]
20. Proliposomes for oral delivery of total biflavonoids extract from
Chen B; Wang X; Lin D; Xu D; Li S; Huang J; Weng S; Lin Z; Zheng Y; Yao H; Lin X
Int J Nanomedicine; 2019; 14():6691-6706. PubMed ID: 31692515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
